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OBJECTIVES The aim of this study was to assess the impact of gender on clinical course and in-hospital
mortality in patients with cardiogenic shock (CS) complicating acute myocardial infarction
(AMI).
BACKGROUND Previous studies have demonstrated higher mortality for women compared with men with ST
elevation myocardial infarctions and higher rates of CS after AMI. The influence of gender
and its interaction with various treatment strategies on clinical outcomes once CS develops is
unclear.
METHODS Using the SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK?
(SHOCK) Registry database of 1,190 patients with suspected CS in the setting of AMI, we
examined shock etiologies by gender. Among the 884 patients with predominant left
ventricular (LV) failure, we compared the patient demographics, angiographic and hemody-
namic findings, treatment approaches as well as the clinical outcomes of women versus men.
This study had a 97% power to detect a 10% absolute difference in mortality by gender.
RESULTS Left ventricular failure was the most frequent cause of CS for both gender groups. Women
in the SHOCK Registry had a significantly higher incidence of mechanical complications
including ventricular septal rupture and acute severe mitral regurgitation. Among patients
with predominant LV failure, women were, on average, 4.6 years older, had a higher
incidence of hypertension, diabetes and a lower cardiac index. The overall mortality rate for
the entire cohort was high (61%). After adjustment for differences in patient demographics
and treatment approaches, there was no significant difference in in-hospital mortality between
the two gender groups (odds ratio 1.03, 95% confidence interval of 0.73 to 1.43, p 0.88).
Mortality was also similar for women and men who were selected for revascularization (44%
vs. 38%, p  0.244).
CONCLUSIONS Women with CS complicating AMI had more frequent adverse clinical characteristics and
mechanical complications. Women derived the same benefit as men from revascularization,
and gender was not independently associated with in-hospital mortality in the SHOCK
Registry. (J Am Coll Cardiol 2001;38:1395–401) © 2001 by the American College of
Cardiology
Myocardial infarction (MI) strikes close to one million
Americans annually (1) and accounted for one of every 4.8
deaths in 1995 (2,3). With the establishment of coronary
care units, advances made in early detection and treatment
of obstructive coronary artery disease and the application of
thrombolytic treatment strategies in acute MI (AMI), the
mortality rate in patients admitted to hospitals with MI has
declined in recent years (2,3). Despite these advances,
mortality associated with cardiogenic shock (CS) compli-
cating MI remains unacceptably high (4,5). Conventional
treatment with intravenous thrombolytic therapy has had
limited impact on 30-day mortality in patients with MI
after pump failure is diagnosed (6). Importantly, women
may have a higher incidence of CS and mortality, compli-
cating acute ST elevation MI, than that seen in men
(4,7–20). However, whether there are gender differences in
treatment approaches and clinical outcomes in patients with
CS is less clear.
The SHould we emergently revascularize Occluded Cor-
onaries for cardiogenic ShocK (SHOCK) trial was a Na-
tional Heart, Lung, and Blood Institute-sponsored multi-
center study designed to assess the impact of a direct
invasive strategy including emergent coronary angiography
and revascularization on 30-day mortality in patients with
AMI complicated by CS. In an effort to ensure that all
potentially eligible patients were screened for the study,
patients with any clinical or hemodynamic evidence of CS
complicating an AMI who were not enrolled in the ran-
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domized trial were entered in the SHOCK Registry. The
purpose of this analysis was to ascertain if there were
differences in procedural utilization and clinical outcomes
between men and women enrolled in the SHOCK Registry.
METHODS
Patients. From April 1993 to August 1997, a total of 1,190
consecutive patients (709 men and 481 women) with
suspected CS complicating AMI, whether meeting all
enrollment criteria for the SHOCK trial or not, were
enrolled in the SHOCK Registry. Reasons for trial ineligi-
bility (and subsequent enrollment in the SHOCK Registry)
have been previously published (5) and included failure to
meet all clinical and hemodynamic inclusion criteria, failure
to adhere to specified time windows, presence of any clinical
exclusion criterion and inability to obtain informed consent.
Patients were enrolled at 36 international clinical sites
including 24 U.S. centers (730 patients), five Canadian
centers (256 patients), four Belgian centers (76 patients) and
one center each in Australia, New Zealand and Brazil (128
patients). All enrolled patients with a local discharge diag-
nosis of AMI with CS (diagnosis related groups [DRGs]
410, 410.1 to 410.9 or combined with 785.51) or a sus-
pected diagnosis of CS complicating AMI, regardless of the
final discharge diagnosis, were entered into the Registry.
Cardiogenic shock due to predominant left ventricular (LV)
failure (see definitions in the following text) was noted in
74% (n  884) of the 1,190 registered patients. Shock
etiologies were examined by gender using the entire Regis-
try cohort. However, in view of significant differences in the
incidence of various etiologies of CS for men and women,
subsequent comparisons of patient characteristics, clinical
findings, hemodynamics and angiographic data by gender,
including multivariate analyses for treatment strategies and
mortality models, were based on the subset of 884 patients
(562 men and 322 women) with predominant LV failure.
Data collection. Patient demographics, MI characteristics,
vascular hemodynamics, procedure utilization and vital sta-
tus at hospital discharge were recorded in standardized case
report forms by centrally trained SHOCK study coordina-
tors and sent to the data coordinating center. Cardiac
catheterization and angioplasty reports were also forwarded
to the clinical coordinating center for abstraction and
centralized completion of a standardized form. Reinfarc-
tion, vasopressor use, history of or elevated lipids and
peripheral vascular disease, cardiac output and pulmonary
artery pressures were recorded on revised data collection
forms only and available for two-thirds of patients. A total
of 568 patients with predominant LV failure underwent
right heart catheterization, with pulmonary capillary wedge
pressure obtained in 533 and cardiac index in 407. Left
ventricular ejection fraction at or after shock development
was measured in 300 patients—36% by left ventriculogra-
phy at any time during the hospitalization; 59% of patients
underwent echocardiogram, and gated blood pool scan was
obtained in 5%.
Definitions. Patients were categorized as having predom-
inant LV failure as the contributing etiology of their CS
when other major causes of CS were absent. These causes
included isolated right ventricular shock, a mechanical cause
(acute severe mitral regurgitation or ventricular septal rup-
ture), tamponade/LV rupture, prior severe valvular heart
disease, dilated cardiomyopathy, excess beta or calcium
channel blockade, shock due to cath lab complications or
other non-cardiac causes of shock.
Global Use of Strategies to Open Occluded Coronary
Arteries (GUSTO) I criteria were used for electrocardio-
gram locations of MI: V1 to V4, anterior; II, III, AVF
inferior; I, AVL, lateral; V1 to V2, posterior and V5 to V6
apical. Creatine kinase (CK) values analyzed were the
highest recorded (based on three or more measurements for
71% of patients).
Reinfarction was defined as: 1) recurrent chest pain or
ischemic symptoms 30 min and recurrent ST segment
elevation, new Q waves or new left bundle branch block, 2)
total CPK at least twice the upper limit of normal and
25% or 200 U/ml over the previous value with an elevated
CK-isoenzyme (MB) level or 3) a rise in CK-MB above the
upper limit of normal after it had reverted to the normal
range.
Statistical methods. Groups were compared using Fisher
exact test for categorical variables, the Wilcoxon rank sum
test for ordinal and non-normally distributed continuous
variables and Student t test for normally distributed contin-
uous variables. In-hospital mortality and selection for an-
giography and revascularization by gender were analyzed
using logistic regression. In order to determine if gender was
an independent predictor of outcome, a multivariate model
was constructed by including all variables with a univariate
p value for gender comparison of 0.20 or less. All variables
with a final p value of 0.05 or less were retained in the
model. This study had 97% power to detect a 10% absolute
Abbreviations and Acronyms
AMI  acute myocardial infarction
CABG  coronary artery bypass grafting
CI  confidence interval
CK(-MB)  creatine kinase (isoenzyme)
CS  cardiogenic shock
DRG  diagnosis related group
GUSTO  Global Use of Strategies to Open Occluded
Coronary Arteries
IABP  intra-aortic balloon pump
LV  left ventricular
MI  myocardial infarction
OR  odds ratio
PCTA  percutaneous transluminal coronary
angioplasty
SHOCK  SHould we emergently revascularize
Occluded Coronaries for cardiogenic
shocK? trial
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difference in mortality by gender, assuming a significance
level of 0.05 and a mortality rate in men of 59%. All analyses
were conducted using the Statistical Analysis System (SAS
Institute, Cary, North Carolina) and S-PLUS for Windows
(Statistical Sciences Inc., Seattle, Washington).
RESULTS
Etiologies of CS. Predominant LV failure after MI was
the most common (74.3%) cause of CS for both men and
women (Table 1). It was more frequently a cause of CS in
men than it was in women (79.3% vs. 66.9%, p  0.001), in
part due to the higher incidence of mechanical complica-
tions in women including development of severe mitral
regurgitation due to papillary muscle dysfunction (11.4% in
women vs. 7.1% in men, p  0.014) and ventricular septal
rupture (7.7% in women vs. 3.5% in men, p  0.003).
Patient characteristics. Of 884 patients with AMI com-
plicated by CS due to predominant LV failure, 322 (36.4%)
were women (Table 2). Female patients were, on average,
4.6 years older and had a higher prevalence of hypertension
(62.1% vs. 45.6%) and diabetes (40.8% vs. 28.3%), while
male patients were more likely to have a history of smoking
(57.5% vs. 40.7%), prior MI (44.7% vs. 32.0%) and previous
bypass surgery (12.1% vs.6.7%; all p  0.001).
Clinical and hemodynamic findings. Patients enrolled in
the SHOCK Registry were critically ill; 96% of patients
with predominant LV failure received vasopressors, and
75% of patients were intubated, with similar rates for
women and men. Infarct locations were also comparable
between the two gender groups with the majority of infarcts
involving the anterior wall (Tables 3 and 4). Both male and
female patients with LV failure had a relatively large
myocardial infarct size with median highest CK of 1,869
IU/ml for men and 1,965 IU/ml for women. The median
time from onset of MI symptoms to diagnosis of CS was
6.2 h and was similar for women and men. Hemodynamics
did not differ by gender, except that cardiac index, largely
measured on inotropic support, was significantly lower in
women than it was in men (1.8  0.6 l/min/M2 vs. 2.2 
0.8 l/min/M2, p  0.001).
Angiographic findings. Coronary angiography was per-
formed at the same rate in women and men (62%), and the
majority (57%) of patients had three-vessel disease (Table
5). There were no significant differences in the extent of
coronary artery disease by gender. The distribution of
infarct-related vessel location was similar for the two
groups. Specifically, the left main coronary artery was
classified as the culprit vessel in 7% of patients, with similar
frequency observed in women and men.
Treatment strategies. The rates of thrombolytic treatment
were similar for men and women (32% for women vs. 36%
for men, p  0.304) (Table 5). However, intra-aortic
balloon pump (IABP) use was less common in women than
it was in men (48% in women vs. 55% in men, p  0.050),
despite a lower cardiac index demonstrated in women.
Women were more likely to receive blood transfusions (47%
for women vs. 35% for men, p  0.001).
Although the overall frequency of coronary angiography
was similar (62%) for women and men with predominant
LV failure (p  1.00), after adjusting for the older age and
greater prevalence of diabetes in women and higher rates of
prior percutaneous transluminal coronary angioplasty
(PTCA), previous coronary artery bypass grafting (CABG),
dilated cardiomyopathy and severe systemic illness in men,
women were more likely to undergo angiography than men
(odds ratio [OR]  1.8, 95% confidence interval [CI] 
1.01 to 1.95, p  0.042).
The rate of percutaneous or surgical revascularization was
similar for the two gender groups. In patients with predom-
inant LV failure, 35% of women and 31% of men under-
went PTCA (p  0.234). In the angiography cohort (in
which 57% of women and 50% of men underwent PTCA),
after adjustment for differences in age, left main disease,
bypass surgery and dilated cardiomyopathy, the frequency of
PTCA remained gender neutral (n 453; OR 1.12, 95%
CI 0.71 to1.78, p 0.624). Similarly, although there was
a higher incidence (17.3% vs. 12.1%, p  0.042) of male
patients undergoing coronary bypass surgery, this gender
Table 2. Baseline Characteristics in Patients With Predominant
LV Failure
Men
(n  562)
Women
(n  322) p Value
Age (yrs) 66.8  12.3 71.4  11.1 0.001
Hx MI (%) 44.7 32.0 0.001
Hx hypertension (%) 45.6 62.1 0.001
Diabetes mellitus (%) 28.3 40.8 0.001
Hx smoking (%) 57.5 40.7 0.001
Hx CABG (%) 12.1 6.7 0.001
Hx PTCA 7.6 5.1 0.200
Hx congestive heart
failure (%)
20.1 19.2 0.788
Hx renal insufficiency (%) 11.4 9.5 0.419
Hx PVD (%) (n  560) 18.6 19.0 0.910
Hx elevated lipids (%)
(n  443)
40.6 39.5 0.841
CABG coronary artery bypass graft surgery; Hx history of; LV left ventricular;
MI  myocardial infarction; PTCA  percutaneous transluminal coronary angio-
plasty; PVD  peripheral vascular disease.
Table 1. Etiologies of Cardiogenic Shock by Gender
Men
(n  709)
Women
(n  481)
p
Value
Predominant left ventricular
failure (%)
79.3 66.9 0.0001
Severe mitral regurgitation (%) 7.1 11.4 0.014
Ventricular septal rupture (%) 3.5 7.7 0.003
Isolated right ventricular
shock (%)
2.8 4.2 0.251
Tamponade (%) 1.1 2.5 0.105
Shock due to cath lab
complications (%)
1.8 2.5 0.520
Active bleeding (%) 4.4 4.4 1.00
Other causes of shock (%) 3.4 4.6 0.288
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difference dissipated after adjusting for the age difference
between the two groups (OR  0.76, 95% CI  0.50 to
1.14, p  0.190). Furthermore, selection of patients for
revascularization (either PTCA or bypass surgery) did not
differ significantly between women and men after adjust-
ment for differences in patient characteristics including age,
dilated cardiomyopathy, diabetes, prior CABG and prior
PTCA (OR  1.27, 95% CI  0.96 to 1.67, p  0.140).
In-hospital mortality. Despite differences in patient char-
acteristics including age, history of diabetes and prior
CABG between women and men, there was no significant
gender difference in in-hospital mortality associated with
MI complicated by CS due to predominant LV failure
(women 63.4% vs. men 59.3%, OR  1.16, 95% CI  0.87
to 1.55, p  0.252) (Fig. 1). This gender neutrality was
maintained even after adjustment for differences in patient
demographics (age, diabetes and prior CABG) as well as for
treatment approaches (CABG and transfusion) between the
two groups (OR 1.03, 95% CI 0.73 to 1.43, p 0.88).
In the subset of patients who underwent right heart cathe-
terization, in-hospital mortality adjusted for differences in
cardiac index as well as other patient and treatment factors
was similar between women and men (OR  0.77, 95%
CI  0.47 to 1.28, p  0.313).
Mortality rates by gender and intervention approaches are
displayed in Figure 1. No differences were found in in-
hospital mortality by gender for patients who underwent
revascularization (44% for women vs. 38% for men, p 
0.244) or for those with no revascularization attempt (79%
for women vs. 78% for men, p  0.818). Mortality rates
after PTCA and CABG were also similar for men and
women (Fig. 1).
DISCUSSION
In the SHOCK Registry, women more often had mechan-
ical etiologies of CS complicating AMI. In addition,
women had a higher risk profile than men, including
advanced age and lower cardiac index. Women and men
underwent revascularization at similar rates. Furthermore,
women derived as much benefit from revascularization as
men.
Gender and MI. The impact of gender on the prognosis
after AMI remains unclear. Previous studies have suggested
that the female gender may carry a worse prognosis after MI
in both the pre- and post-thrombolytic era (7–20). The
conclusions reached by these investigations were often
limited by the sample size and lack of adjustment for other
confounding variables (7,8). On the other hand, there are
other well-designed retrospective studies documenting fe-
male patients who have fared as well as their male counter-
parts (21–31).
Table 3. Myocardial Infarction Characteristics in Patients With Predominant LV Failure
Men
(n  562)
Women
(n  322) p Value
MI location
Anterior (%) 58.8 58.8 1.00
Inferior (%) 43.0 44.0 0.824
Posterior (%) 17.9 16.4 0.627
Lateral (%) 31.7 32.3 0.825
Apical (%) 8.8 10.9 0.382
Highest total CK (IU/ml)
Median 1,869 (622, 4,193)* 1,965 (652, 3,960)* 0.703
Highest CK/normal limit
Median 8.4 (2.7, 19.0)* 10.3 (3.1, 20.2)* 0.122
MI to shock (h)
Median 5.8 (1.7, 20.5)* 7.5 (2.0, 19.5)* 0.458
*Numbers in parentheses denote 25th and 75th percentiles.
CK  creatine kinase; LV  left ventricular; MI  myocardial infarction.
Table 4. Hemodynamic Findings in Patients With Predominant LV Failure
n Men Women p Value
Heart rate (beats/min) 832 94.9  26.3 95.5  24.8 0.726
Systolic blood pressure (mm Hg) 833 87.9  22.2 89.2  24.2 0.417
Diastolic blood pressure (mm Hg) 729 53.4  17.2 51.7  17.1 0.215
LVEF (%) 300 29.1  12.0 31.4  13.4 0.147
Right heart catheterization 568 63.0% 66.5% 0.308
PCWP (mm Hg) 533 24.1  8.9 23.0  8.0 0.138
PA systolic (mm Hg) 239 42.1  14.0 39.7  10.7 0.207
Cardiac output (l/min) 281 4.3  1.7 3.2  1.1 0.001
Cardiac index (l/min/M2) 407 2.2  0.8 1.8  0.6 0.001
Values obtained close to shock onset and often on support measures.
LVEF  left ventricular ejection fraction same day as or after shock; PA  pulmonary artery. PCWP  pulmonary capillary
wedge pressure;
1398 Wong et al. JACC Vol. 38, No. 5, 2001
Gender and Clinical Outcomes in Cardiogenic Shock November 1, 2001:1395–401
The apparent increase in mortality in AMI in women
might be attributed to a variety of other confounding
variables including delayed presentation to the hospital for
treatment. Once in the hospital, women seemed to be less
likely to receive thrombolysis, undergo catheterization, an-
gioplasty or bypass surgery (16–18). An extensive review by
Vaccarino et al. (32) based on 27 published reports from
1966 through 1994 reported no difference in early mortality
between women and men after MI. Stone et al. (33), using
the Primary Angioplasty in MI database, were able to
demonstrate that gender was not an independent predictor
for in-hospital mortality. Indeed, female gender treated
with PTCA was independently associated with improved
in-hospital survival. Malacrida et al. (34), using the Third
International Study of Infarct Survival database, evaluated
early (35-day) mortality in 9,600 women and 26,480 men
with suspected MI and noted that the female gender had a
small independent adverse effect on early mortality and
morbidity with an OR of 1.14 (95% CI  1.05 to 1.23).
More in-depth evaluation of the TIMI 2 and 3 as well as
GUSTO 2 studies revealed that the higher mortality in
women was seen with ST elevation MI only; similar clinical
outcomes were reported for men and women with non-ST
elevation MI (35–37). Hochman et al. (37) proposed that
perhaps reduced collateral flow in women may account for
more prevalent angina with less severe coronary artery
obstructions and more frequent complications, including a
higher incidence of CS and mechanical complications (ven-
tricular septal rupture and severe mitral regurgitation), in
women with AMI compared with men.
Interestingly, a recent analysis using the National Regis-
try of MI 2 database involving more than 384,000 patients,
Table 5. Angiographic Findings and Treatment Approaches in
Patients With Predominant LV Failure
Men
(n  292)
Women
(n  172)
p
Value
Angiogram (%) 62.3 62.1 1.00
Left main disease (%) 18.4 15.8 0.474
Number of vessel disease (%) 0.329
0 0.7 1.2
1 19.9 26.6
2 21.3 18.5
3 58.1 53.8
Culprit vessel (%) 0.284
Left anterior descending 42.8 46.0
Circumflex 14.1 14.3
Right coronary artery 25.5 29.8
Left main 7.8 5.0
SVG 9.8 5.0
Treatment received (%)
Thrombolysis 36.0 32.4 0.304
Vasopressors (n  633) 95.3 96.5 0.543
Ventilation support 75.8 74.5 0.686
Intra-aortic balloon pump 55.2 48.1 0.050
Transfusion 35.2 46.6 0.001
PTCA 31.3 35.4 0.234
CABG 17.3 12.1 0.042
CABG  coronary artery bypass surgery; LV  left ventricular; PTCA  percuta-
neous transluminal coronary angioplasty; SVG  saphenous vein graft.
Figure 1. In-hospital mortality (%) in patients with predominant left ventricular failure. CABG  coronary artery bypass grafting; PTCA  percutaneous
transluminal coronary angioplasty.
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Vaccarino et al. (38) concluded that in-hospital mortality
after AMI was higher in younger but not older (75 years
old) women compared with men. This difference in clinical
outcome may be, in part, due to differences in the patho-
anatomy of coronary lesions (plaque erosion vs. rupture) or
pathophysiology (a higher incidence of coronary spasm and
higher platelet activity or reduced collateral flow) of younger
versus older women (39).
Present study. Consistent with the findings of the
Worcester Heart Attack study showing that women devel-
oped CS more often than men (4), the SHOCK Registry
had a high prevalence (40%) of women in-patients with CS
complicating AMI when compared with the 25% to 30% of
female gender in large MI series (39–41). In the SHOCK
Registry, women were more likely to receive transfusions
than men during their hospital stay. This may reflect more
frequent bleeding complications associated with invasive
procedures in older female patients (42). In addition to
more frequent bleeding complications, the overall smaller
artery size in female patients may contribute to the lower
IABP utilization in women than it did in men in the
Registry. Other patient demographics, including older age
and a higher prevalence of hypertension and diabetes in the
female patients in the SHOCK Registry, were similar to
other AMI series. Importantly, our Registry demonstrated
that there was no difference in the treatment approaches
between the two gender groups. Indeed, the SHOCK
Registry data demonstrated that women underwent cathe-
terization more frequently than men. Moreover, the clinical
outcomes after PTCA and CABG were similar for men and
women. These differences in treatment approaches and the
resulting clinical outcomes may be due to changes in
practice pattern over time. Alternatively, the profound
acuity of the disease state that was present in the majority of
patients with CS may neutralize any potential gender
differences in pathoanatomy, treatment strategies or clinical
outcomes that have been reported in other AMI series and
in studies involving patients in more elective settings.
Study limitations. We cannot rule out that a dispropor-
tionate number of men or women with shock died before
presentation to the hospitals; therefore, the relative mortal-
ity rates only reflect those of patients who reach the hospital.
Given that the database is a registry of patients who either
failed to meet all the enrollment criteria or refused to
participate in the multicenter randomized SHOCK trial,
there are inherent biases that might have contributed to
some of the differences observed in the clinical findings or
treatment approaches used in Registry versus trial patients.
Furthermore, although the Registry data were prospectively
collected, they are observational only, and, therefore, hemo-
dynamic and angiographic findings are based on only those
patients who were selected to undergo right and left heart
catheterization.
Conclusions. Despite more frequent adverse clinical char-
acteristics and associated mechanical complications in
women with CS, gender was not an independent predictor
of in-hospital mortality in the SHOCK Registry patients
with predominant LV failure. After adjusting for differences
in patient characteristics between men and women, there
was no gender bias in patient selection for revascularization
in the SHOCK Registry. Furthermore, the apparent benefit
derived from PTCA and CABG was similarly observed for
both men and women.
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